Routine FFR/iFR Reclassifies Treatment Strategies in Half of Cases

Routine invasive physiology assessment at time of angiography reclassifies treatment strategies in a big number of patients with lesions in 2 or 3 vessels, according to the multicenter prospective study DEFINE REAL, recently published in JACC Cardiovascular Interventions.

El FFR/iFR rutinario reclasifica la estrategia de tratamiento en casi la mitad de los casos

The information obtained by measuring fractional flow reserve (FFR) or instantaneous wave free ratio (iFR) made interventionists modify their original plans in 45% of cases. Reclassification was higher as more vessels were assessed, reaching an astonishing 66.7% for cases when 3 epicardial vessels were assessed.


Leia também: DEFINE FLAIR and IFR SWEDEHEART: Safety in Revascularization Based on FFR and iFR in Both Stable and ACS Patients.


These findings now published in JACC had been originally presented at EuroPCR and are consistent with prior studies (R3F, RIPCORD, POST-IT), though these mostly included patients with one vessel disease. DEFINE REAL is the first invasive physiology study to focus on patients with multivessel disease.

 

The message is loud and clear and, at the same time, challenging: invasive physiology study of all vessels is mandatory, even in patients with non-invasive tests suggesting ischemia prior catheterization. In turn, this raises the question: does the change of strategy convey a change in prognosis?

 

DEFINE REAL was carried out in 18 centers across 9 countries and included 484 patients with multivessel disease undergoing diagnostic angiography (73.3% presented 2 vessel disease, and 26.7% 3 vessel disease).


Leia também: What Is the Long-Term Outcome of Lesions Deferred Using FFR/iFR?


Researchers first defined an initial strategy based on  angiography and clinical assessment, then performed a physiology assessment, one third with iFR and the rest with FFR, and the final strategy was defined.

 

The change of plans, thanks to FFR/iFR, increased the use of medical treatment and myocardial revascularization surgery and modestly reduced the use of PCI.

 

The use of iFR was associated with less symptoms and the chance to assess more vessels, which resulted in a higher rate of reclassification than that obtained with the use of FFR (57.5% vs 39.9%).


Leia também: Surprisingly, some patients won’t do as told and have less events.


This study does not provide any information on clinical results, which remains to be sorted out by future studies. For now, the best we have are the SYNTAX II outcomes, published last year, which showed physiology assessment had very good results.

 

Título original: Impact of routine invasive physiology at time of angiography in patients with multivessel coronary artery disease on reclassification of revascularization strategy: results from the DEFINE REAL study.

Referencia: Van Belle E et al. J Am Coll Cardiol Intv. 2018;11:354-365.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

Sua opinião nos interessa. Pode deixar abaixo seu comentário, reflexão, pergunta ou o que desejar. Será mais que bem-vindo.

More articles by this author

AHA 2025 | OCEAN Study: Anticoagulation vs. Antiplatelet Therapy After Successful Atrial Fibrillation Ablation

After a successful atrial fibrillation (AF) ablation, the need to maintain long-term anticoagulation (AC) remains uncertain, especially considering the very low residual embolic risk...

AHA 2025 | VESALIUS-CV: Evolocumab in High-Cardiovascular-Risk Patients Without Prior MI or Stroke

LDL cholesterol is a well-established factor for cardiovascular disease. Therapy with PCSK9 inhibitors, including evolocumab, has been shown to reduce the risk of cardiovascular...

AHA 2025 | TUXEDO-2: Post-PCI Antiplatelet Management in Diabetic Patients with Multivessel Disease — Ticagrelor or Prasugrel?

Choosing the optimal P2Y12 inhibitor for diabetic patients with multivessel coronary artery disease undergoing percutaneous coronary intervention (PCI) remains a major clinical challenge. These...

AHA 2025 | DECAF: Coffee Consumption vs. Abstinence in Patients with Atrial Fibrillation: Recurrence or Myth?

The link between coffee consumption and arrhythmia has been met with contradicting recommendations. It is widely believed that caffeine could trigger atrial fibrillation (AF)...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Atrial Fibrillation After Percutaneous Patent Foramen Ovale Closure: Cohort Study with Continuous Implantable Cardiac Monitoring

Atrial fibrillation (AF) is a recognized complication following percutaneous closure of a patent foramen ovale (PFO), with reported incidences of up to 30% during...

Impact of Baseline Systolic Blood Pressure on Blood Pressure Changes Following Renal Denervation

Renal denervation (RDN) is a guideline-recommended therapy to reduce blood pressure in patients with uncontrolled hypertension, although uncertainties remain regarding which factors best predict...

AHA 2025 | OPTIMA-AF: 1 Month vs. 12 Months of Dual Therapy (DOAC + P2Y12) After PCI in Atrial Fibrillation

Concomitant atrial fibrillation (AF) and coronary artery disease is a common occurrence in clinical practice. In these patients, current guidelines recommend 1 month of...